Systems biology towards novel chronic kidney disease diagnosis and treatment
Chronic kidney disease (CKD) affects up to 10% of the population. Besides eventual progression towards end stage renal disease CKD impacts the patient s quality of life by causing serious comorbidities including cardiovascular complications and bone metabolism disorders. On the everyday clinical level early stage diagnosis and tailored treatment of CKD are still inadequate.
See more:
Short name and number:
SysKID (241544)
Name of US Partner:
CELERA CORPORATION
Contact:
EMERGENTEC BIODEVELOPMENT GMBH (NL)
Participating Countries:
Switzerland
Area:
Health
Category:
FP7 Project with U.S. partner
